Bank Of New York Mellon Corp Eliem Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.77 - $8.4 $38,483 - $116,701	-13,893 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$8.01 - $13.15 $1,297 - $2,130	-162 Reduced 1.15%	13,893 $117,000
Q4 2021 Feb 11, 2022	BUY	$8.61 - $20.47 $7,292 - $17,338	847 Added 6.41%	14,055 $147,000
Q3 2021 Nov 12, 2021	BUY	$14.45 - $28.61 $190,855 - $377,880	13,208 New	13,208 $237,000

53.1M

Ticker ELYM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,567,700
Market Cap $109M
Description
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.